I agree, in the absence of any post-marketing safety issues, it makes sense that this will be the delivery approach for these drugs in the future.
As I was saying before, the economic opportunity will be linked to the granting and defensibility of patents. Otherwise will be a very competitive, low margin business.
I agree, in the absence of any post-marketing safety issues, it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $31.34M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.5¢ | $30.22K | 108.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 77869 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 50000 | 2 |
View Market Depth
| Last trade - 11.09am 19/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |